Position in IDYA
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$8,522,056
-$105,093 QoQ
Shares Held
255,764
-51.4% QoQ
Ownership
0.291%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
6 quarters on record
Voting authority
Sole 37.5260005317402.ToString("F0")%
Shared 0.ToString("F0")%
None 62.4739994682598.ToString("F0")%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JENNISON ASSOCIATES LLC holds $3,287,290,858 across 47 Biotechnology names. IDYA ranks #39 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,740,059 | $1,223,545,945 | |
| 2 | ARGX |
Argenx SE
|
237,468 | $173,411,007 | |
| 3 | SRRK |
Scholar Rock Holding Corp
|
3,340,492 | $164,218,586 | |
| 4 | TARS |
Tarsus Pharmaceuticals, Inc.
|
1,712,124 | $120,105,497 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
4,980,770 | $117,346,940 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
1,072,011 | $112,989,959 | |
| 7 | INSM |
INSMED Inc
|
604,694 | $98,879,562 | |
| 8 | PCVX |
Vaxcyte, Inc.
|
1,698,011 | $98,671,418 |
All Filings in IDYA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,522,056 | 255,764 | Shares | Defined | 2026-05-06 | |
| 2025-03-31 | $8,627,149 | 526,688 | Shares | Defined | 2025-05-05 | |
| 2024-12-31 | $25,048,145 | 974,636 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $30,801,386 | 972,266 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $14,425,364 | 410,862 | Shares | Defined | 2024-08-05 | |
| 2024-03-31 | $11,244,206 | 256,249 | Shares | Defined | 2024-05-02 | |
| No filing history on record for this holder in this stock. | ||||||